Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | MGLL | Q99685 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.32 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.32 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Magnesium Chloride Anhydrous SCHEMBL20694938 | 0.92 | CA4 (0.32) | CA4CA6CA5ACA7ENPP2 | |
| SCHEMBL8212797 | 0.82 | CA4 (0.33) | CA4CA6CA5ACA7ENPP2 | |
| SCHEMBL6013736 | 0.71 | HSD17B10 (0.33) | CA4CA6CA5ACA7ENPP2 | |
| SCHEMBL276957 | 0.70 | CYP1A2 (0.42) | HSD17B10TDP1KDM4EALDH1A1CYP2A6 | |
| SCHEMBL26639108 | 0.70 | ALOX5 (0.34) | CA4CA6CA5ACA7ENPP2 | |
| SCHEMBL15058729 | 0.69 | PTPN1 (0.33) | HSD17B10TDP1KDM4EALDH1A1CYP2A6 | |
| SCHEMBL28306537 | 0.68 | CYP1A2 (0.41) | HSD17B10TDP1KDM4EALDH1A1CYP2A6 | |
| SCHEMBL6531740 | 0.67 | TSHR (0.37) | HSD17B10TDP1KDM4EALDH1A1CYP2A6 | |
| SCHEMBL4079696 | 0.65 | CYP2A6 (0.42) | HSD17B10TDP1ALDH1A1CYP2A6TSHR | |
| SCHEMBL21179481 | 0.65 | ALDH1A1 (0.39) | HSD17B10TDP1ALDH1A1CYP2A6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 609 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2081946-A2 | ADENOSINE DERIVATIVES FOR THE TREATMENT OF PAIN | Biovitrum AB (publ) (SE) | 2009-07-29 | — | — | EP | claimed |
| WO-2008000745-A2 | ADENOSINE DERIVATIVES FOR THE TREATMENT OF PAIN | BIOVITRUM AB (PUBL) (SE) | 2008-01-03 | — | — | WO | claimed |
| US-12630522-B2 | Compound for organic optoelectronic device, composition for organic optoelectronic device, and organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2026-05-19 | — | — | US | disclosed |
| US-12522813-B2 | Mannanase for formulations having pH 5-12 | BASF SE (DE) | 2026-01-13 | — | — | US | disclosed |
| US-12492216-B2 | Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2025-12-09 | — | — | US | disclosed |
| US-20250339445-A1 | Modulators of Orphan Nuclear Receptors for Treating Pancreatitis, Glioblastoma, Sarcopenia and Stroke | UNIV EMORY (US) | 2025-11-06 | — | — | US | disclosed |
| EP-3787631-B1 | MODULATORS OF ORPHAN NUCLEAR RECEPTORS FOR NASH AND OTHER METABOLIC DISORDERS | UNIV EMORY (US) | 2025-09-10 | — | — | EP | disclosed |
| US-12410200-B2 | Composition for organic optoelectronic device, organic optoelectronic device, and display device | SAMSUNG SDI CO., LTD. (KR) | 2025-09-09 | — | — | US | disclosed |
| US-20250234861-A1 | LACTONES FOR ENHANCING THE ACTIVITY OF ANTIMICROBIAL AGENTS | BASF SE (DE) | 2025-07-24 | — | — | US | disclosed |
| US-20250188053-A1 | PYRIMIDINE TRICYCLIC ENONE DERIVATIVES FOR INHIBITION OF ROR-GAMMA AND OTHER USES | REATA PHARMACEUTICALS, INC. (US) | 2025-06-12 | — | — | US | disclosed |
| US-12318393-B2 | Modulators of orphan nuclear receptors for NASH and other metabolic disorders | EMORY UNIVERSITY | 2025-06-03 | — | — | US | disclosed |
| EP-1206457-A1 | BIARYL-OXA(THIA)ZOLE DERIVATIVES AND THEIR USE AS PPARS MODULATORS | ELI LILLY AND COMPANY (US) | 2002-05-22 | — | — | EP | disclosed |
| WO-2002028837-A1 | METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA N.V. (BE) | 2002-04-11 | — | — | WO | disclosed |
| US-20020028938-A1 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | BLACK LAWRENCE A (US) | 2002-03-07 | — | — | US | disclosed |
| WO-2002010137-A2 | INDAZOLE DERIVATIVES AS JNK INHIBITORS | SIGNAL PHARMACEUTICALS, INC. (US) | 2002-02-07 | — | — | WO | disclosed |
| US-20020013318-A1 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | BLACK LAWRENCE A (US) | 2002-01-31 | — | — | US | disclosed |
| US-6307047-B1 | PYRIDAZINONE COMPOUNDS; INHIBITORS OF CYCLOOXYGENASE-2 (COX-2); SELECTIVITY OF THESE COMPOUNDS FOR COX-2 MINIMIZES THE UNWANTED GI AND RENAL SIDE-EFFECTS SEEN WITH CURRENTLY MARKETED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | ABBOTT LABORATORIES | 2001-10-23 | — | — | US | disclosed |
| EP-1124804-A1 | PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE BIOSYNTHESIS INHIBITORS | ABBOTT LABORATORIES (US) | 2001-08-22 | — | — | EP | disclosed |
| WO-2001016120-A1 | BIARYL-OXA(THIA)ZOLE DERIVATIVES AND THEIR USE AS PPARS MODULATORS | ELI LILLY AND COMPANY (US) | 2001-03-08 | — | — | WO | disclosed |
| WO-2000024719-A1 | PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE BIOSYNTHESIS INHIBITORS | ABBOTT LABORATORIES (US) | 2000-05-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12492216-B2 | Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display device | OCIAD2, OCIAD1, OXER1 | CA4 1590/4885CA6 1207/4885CA5A 4466/4885 |
| US-20250234861-A1 | LACTONES FOR ENHANCING THE ACTIVITY OF ANTIMICROBIAL AGENTS | CYP51A1, LSS, OLA1 | CA4 3794/4885CA6 3874/4885CA5A 1786/4885 |
| US-20020028938-A1 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | PTGS1, PTGIS, PTGS2 | CA4 4813/4885CA6 4571/4885CA5A 953/4885 |
| US-12410200-B2 | Composition for organic optoelectronic device, organic optoelectronic device, and display device | OCIAD2, OR10J3, OCIAD1 | CA4 1212/4885CA6 1141/4885CA5A 4292/4885 |
| US-12318393-B2 | Modulators of orphan nuclear receptors for NASH and other metabolic disorders | RORA, RORB, RORC | CA4 3429/4885CA6 2811/4885CA5A 1365/4885 |
| US-20250339445-A1 | Modulators of Orphan Nuclear Receptors for Treating Pancreatitis, Glioblastoma, Sarcopenia and Stroke | RXRA, RXRG, RXRB | CA4 2860/4885CA6 2818/4885CA5A 3669/4885 |
| US-12630522-B2 | Compound for organic optoelectronic device, composition for organic optoelectronic device, and organic optoelectronic device and display device | OXER1, OR10J3, CHRM1 | CA4 1450/4885CA6 1641/4885CA5A 4657/4885 |
| US-20250188053-A1 | PYRIMIDINE TRICYCLIC ENONE DERIVATIVES FOR INHIBITION OF ROR-GAMMA AND OTHER USES | RORC, RORB, RORA | CA4 4247/4885CA6 3945/4885CA5A 2000/4885 |
| US-20020013318-A1 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | PTGS1, PTGIS, PTGS2 | CA4 4813/4885CA6 4571/4885CA5A 953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.